Stay updated on OPUS Clinical Trial: Natalizumab in Focal Epilepsy

Sign up to get notified when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.
Latest website image capture
Clouds background image

Latest updates to the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous detailed study record content with a minimal access-restricted screen.
    Difference
    18%
    Check dated 2026-09-21T21:00:08.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing Revision: v3.6.5. This is a metadata update indicating the page version rather than any substantive content change.
    Difference
    0.0%
    Check dated 2026-08-31T17:16:26.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A '2017 ( U.S. NIH Grant/Contract )' entry was added to the study's identifiers, indicating NIH funding and placing it among the other study IDs.
    Difference
    0.0%
    Check dated 2026-08-24T17:14:58.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5. This signals a newer version of the page rather than a content change.
    Difference
    0.0%
    Check dated 2026-08-10T10:48:00.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The revision tag at the bottom of the page was updated to v3.6.4, indicating a newer version of the study record.
    Difference
    0.0%
    Check dated 2026-07-27T06:28:26.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page's revision was updated to v3.6.3 from v3.6.2, indicating a minor update to the entry rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-05T11:53:29.000Z thumbnail image

Stay in the know with updates to OPUS Clinical Trial: Natalizumab in Focal Epilepsy

Enter your email address, and we'll notify you when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.